China's Sinovation reaches $250m mark on fifth VC fund
China-focused Sinovation Ventures reached a USD 200m first close on its fifth flagship US dollar-denominated fund in April and is currently around the USD 250m mark against a target of USD 500m.
AVCJ learned of the development from a source close to the situation. The source added that Sinovation achieved a final close of around USD 600m on its debut growth-stage PE fund - which focuses on...
More on GPs
Latest News
Co-Stone leads $43m round for China biosynthesis player
Co-Stone Capital Management has led a CNY 300m (USD 43m) Series B round for Readline, a Shenzhen-based company that specialises in synthetic biology.
Australia’s Heal Partners closes debut fund on $137m
Australia’s Heal Partners, a health, education, and lifestyle-focused venture capital firm, has closed its first fund on AUD 200m (USD 137m). The target was AUD 100m.
US regulator gets access to Chinese audits
The threat of delisting that has haunted Chinese companies that trade on US exchanges appears to have receded after the US regulators announced they had gained full access to the audits of these companies for the first time.
